Stocks · Health care · Pharmaceutical Preparations

Viking Therapeutics, Inc.

VKTX Clue Score32

United States Fiscal year ends December CIK 0001607678 Results filed 28 Oct 2026

Add to watchlist

What the insiders did Net selling

Individual transactions

Insider

Date

Role

Action

Price

Amount

Matthew W Foehr

11 Apr 2025

Director

Exercised, kept

20,786

$8.00

$166.29K

Marianna Mancini

30 Mar 2023

Chief Operating Officer

Exercised, kept

3,000

$6.47

$19.41K

Marianna Mancini

30 Mar 2023

Chief Operating Officer

Exercised, kept

10,000

$7.69

$76.90K

Marianna Mancini

30 Mar 2023

Chief Operating Officer

Exercised, kept

23,100

$8.52

$196.81K

Matthew W Foehr

22 Mar 2021

Director

Exercised, kept

20,000

$1.50

$30.00K

Show all 125 transactions →

What was left out

Form 4 filings counted 173

Amendments (4/A) skipped 2

Filings about a different issuer 0

Unreadable filings 0

Joint filings 0

Sales on a Rule 10b5-1 plan 1

Sales straight out of an exercise 66

Sales at will 44

Transactions with no price 0

Shares from compensation/vesting 8,612,884

Sales filed before the plan box existed 5

History held since 30 Apr 2015